People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Juvaris Bio Therapeutics Inc | — | Biotechnology | Series B | $15.9M | $29.8M | 2009 |
Carol L. Brosgart at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carol L. Brosgart on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Ross | 1 | 18 |
| Lewis T. Williams | 1 | 5 |
| Michael L. Ross | 1 | 3 |
| Grant E Pickering | 1 | 2 |
| Thomas P. Monath | 1 | 2 |
| Kimberlee E. Gonzaga | 1 | 1 |
| Kimberlee Gonzaga | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.